HEXO (NASDAQ: HEXO)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.040 | -0.340 | -0.3000 | ||||
REV | 45.569M |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | ||||||
REV | 52.763M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of HEXO (NASDAQ: HEXO) through any online brokerage.
There are no as such competitors for HEXO.
The latest price target for HEXO (NASDAQ: HEXO) was reported by Alliance Global Partners on Wednesday, June 15, 2022. The analyst firm set a price target for 0.30 expecting HEXO to rise to within 12 months (a possible 46.27% upside). 2 analyst firms have reported ratings in the last year.
The stock price for HEXO (NASDAQ: HEXO) is $0.2051 last updated August 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for HEXO.
HEXO’s Q3 earnings are confirmed for Tuesday, June 14, 2022.
There is no upcoming split for HEXO.
HEXO is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.